Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 10, 2016-12 ,pp. : 1290-1298

Bentham Science Publishers

Access to resources Recommend Favorite

Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters

By Beque J.-C.   Lavoie N.   de Montigny C.   Debonnel G.  

European Journal of Pharmacology, Vol. 349, Iss. 1, 1998-05 ,pp. : 129-132

Elsevier

Access to resources Recommend Favorite

Is pindolol augmentation effective in depressed patients resistant to selective serotonin reuptake inhibitors? A systematic review and meta‐analysis

By  

Human Psychopharmacology: Clinical And Experimental (Electronic), Vol. 30, Iss. 3, 2015-05 ,pp. : 132-142

John Wiley & Sons Inc

Access to resources Recommend Favorite

Medical Resource Use and Cost of Venlafaxine or Tricyclic Antidepressant Therapy: Following Selective Serotonin Reuptake Inhibitor Therapy for Depression

By Griffiths R.I.  

PharmacoEconomics, Vol. 15, Iss. 5, 1999-05 ,pp. : 495-505

Adis International

Access to resources Recommend Favorite

Use of Bayesian Net Benefit Regression Model to Examine the Impact of Generic Drug Entry on the Cost Effectiveness of Selective Serotonin Reuptake Inhibitors in Elderly Depressed Patients

By Ya-Chen Tina Shih   Bekele Nebiyou B.   Xu Ying  

PharmacoEconomics, Vol. 25, Iss. 10, 2007-01 ,pp. : 843-862

Adis International

Access to resources Recommend Favorite